Holger Knoth

1.1k total citations
40 papers, 738 citations indexed

About

Holger Knoth is a scholar working on Surgery, Geriatrics and Gerontology and Infectious Diseases. According to data from OpenAlex, Holger Knoth has authored 40 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Geriatrics and Gerontology and 8 papers in Infectious Diseases. Recurrent topics in Holger Knoth's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Antifungal resistance and susceptibility (7 papers) and Pharmaceutical studies and practices (6 papers). Holger Knoth is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Antifungal resistance and susceptibility (7 papers) and Pharmaceutical studies and practices (6 papers). Holger Knoth collaborates with scholars based in Germany and France. Holger Knoth's co-authors include Martin Bornhäuser, Johannes Schetelig, Uta Oelschlaegel, J. Radke, Xina Graehlert, Alexander Kiani, Martin Wermke, Christian Thiede, Brigitte Mohr and Christoph Röllig and has published in prestigious journals such as Gastroenterology, British Journal of Cancer and Thrombosis and Haemostasis.

In The Last Decade

Holger Knoth

39 papers receiving 721 citations

Peers

Holger Knoth
Stefanie Howaldt Germany
Clyde D. Ford United States
H. Ruder Germany
Nahoko Yata Japan
Erwin Dreesen Belgium
John Mondick United States
Emanuele Nicastro Italy
Bernard L. Marini United States
Brian Huang United States
J Biollaz Switzerland
Stefanie Howaldt Germany
Holger Knoth
Citations per year, relative to Holger Knoth Holger Knoth (= 1×) peers Stefanie Howaldt

Countries citing papers authored by Holger Knoth

Since Specialization
Citations

This map shows the geographic impact of Holger Knoth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Knoth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Knoth more than expected).

Fields of papers citing papers by Holger Knoth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Knoth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Knoth. The network helps show where Holger Knoth may publish in the future.

Co-authorship network of co-authors of Holger Knoth

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Knoth. A scholar is included among the top collaborators of Holger Knoth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Knoth. Holger Knoth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fischer, Andreas, et al.. (2023). Scoring-Tool zu Identifizierung von Patienten mit erhöhtem Risiko für Arzneimittel-bezogene Probleme- Bericht einer Punkt-Prävalenzuntersuchung bei Aufnahme im Krankenhaus. DMW - Deutsche Medizinische Wochenschrift. 148(23). e113–e119. 1 indexed citations
2.
Knoth, Holger, et al.. (2023). Medikationsanalysen in öffentlichen Apotheken: Konzept zur externen Qualitätsüberprüfung. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 176. 22–30. 2 indexed citations
3.
Heuschkel, Sandra, Raphael Teipel, Simone von Bonin, et al.. (2021). Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury. Cancer Chemotherapy and Pharmacology. 89(1). 41–48. 6 indexed citations
4.
Seeling, Andreas, et al.. (2019). Analysis of secondary care data to evaluate the clinical relevance of the drug-drug interaction between amlodipine and simvastatin. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 146. 21–27. 5 indexed citations
5.
Schulz, Cláudia, Andreas Fischer, Claudia Langebrake, et al.. (2019). Clinical pharmacy services in Germany: a national survey. European Journal of Hospital Pharmacy. 28(6). 301–305. 21 indexed citations
6.
Oertel, Reinhard, Johannes Schetelig, Jan Moritz Middeke, et al.. (2016). Simultaneous determination of clofarabine and cytarabine in human plasma by LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 125. 286–291. 11 indexed citations
7.
Welsch, Thilo, Benjamin Müssle, Marius Distler, et al.. (2016). Cost-effectiveness comparison of prophylactic octreotide and pasireotide for prevention of fistula after pancreatic surgery. Langenbeck s Archives of Surgery. 401(7). 1027–1035. 10 indexed citations
8.
Steib–Bauert, Michaela, Winfried V. Kern, Holger Knoth, et al.. (2015). Hospital use of systemic antifungal drugs: a multi-center surveillance update from Germany. Infection. 43(4). 423–429. 26 indexed citations
9.
Timpel, Patrick, Robert Gurke, Conrad Marx, Holger Knoth, & Joachim Fauler. (2015). Antibiotikaeintrag in das urbane Abwasser. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 59(2). 274–283. 2 indexed citations
10.
Rieger, C., Oliver A. Cornely, Torsten Hoppe‐Tichy, et al.. (2012). Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals. Mycoses. 55(6). 514–520. 20 indexed citations
11.
Lützner, Jörg, Lars Donath, Luise Tittl, et al.. (2012). Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery. Thrombosis and Haemostasis. 109(1). 154–163. 43 indexed citations
12.
Platzbecker, Uwe, Martin Wermke, J. Radke, et al.. (2011). Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial. Leukemia. 26(3). 381–389. 293 indexed citations
13.
Leopold, Claudia S., et al.. (2011). Drug retention by inline filters – Effect of positively charged polyethersulfone filter membranes on drug solutions with low concentration. European Journal of Pharmaceutical Sciences. 44(1-2). 49–56. 10 indexed citations
14.
Miehlke, Stephan, Wulf Schneider‐Brachert, Eberhard Kuhlisch, et al.. (2011). Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection. Helicobacter. 16(6). 420–426. 42 indexed citations
15.
16.
Oertel, Reinhard, et al.. (2009). Contamination of 0.2-micrometer infusion filters by N,N-dimethylacrylamide. Journal of Critical Care. 25(1). 172.e9–172.e14. 1 indexed citations
17.
With, Katja de, Michaela Steib–Bauert, Holger Knoth, et al.. (2005). Hospital use of systemic antifungal drugs. PubMed. 5(1). 1–1. 37 indexed citations
18.
Miehlke, Stephan, Ahmed Madisch, Christian Kirsch, et al.. (2005). Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily – a randomized, two‐way crossover study. Alimentary Pharmacology & Therapeutics. 21(8). 963–967. 31 indexed citations
19.
Hartmann, Michael, et al.. (2004). Report of a user-satisfaction analysis of a service provider for an oncology clinic. Journal of Cancer Research and Clinical Oncology. 130(2). 93–98. 2 indexed citations
20.
Hartmann, Michael, et al.. (2003). Industry-sponsored economic studies in oncology vs studies sponsored by nonprofit organisations. British Journal of Cancer. 89(8). 1405–1408. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefanie Howaldt Breakdown of academic impact, for papers by Clyde D. Ford Breakdown of academic impact, for papers by H. Ruder Breakdown of academic impact, for papers by Nahoko Yata Breakdown of academic impact, for papers by Erwin Dreesen Breakdown of academic impact, for papers by John Mondick Breakdown of academic impact, for papers by Emanuele Nicastro Breakdown of academic impact, for papers by Bernard L. Marini Breakdown of academic impact, for papers by Brian Huang Breakdown of academic impact, for papers by J Biollaz
Rankless by CCL
2026